Current Report Filing (8-k)
August 10 2020 - 7:46AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): August 10, 2020
InspireMD,
Inc.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-35731
|
|
26-2123838
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
4
Menorat Hamaor St.
Tel
Aviv, Israel
|
|
6744832
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
(888)
776-6804
(Registrant’s
telephone number, including area code)
N/A
(Former
Name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of exchange on which registered
|
Common
Stock, par value $0.0001 per share
|
|
NSPR
|
|
NYSE
American
|
Warrants,
exercisable for one share of Common Stock
|
|
NSPR.WS
|
|
NYSE
American
|
Series
B Warrants, exercisable for one share of Common Stock
|
|
NSPR.WSB
|
|
NYSE
American
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item
8.01 Other Events.
On
August 10, 2020, InspireMD, Inc. (the “Company”) issued a press release announcing that, effective as of August
7, 2020, it now complies with all of the NYSE American LLC continued listing standards set forth in Part 10 of the NYSE American
Company Guide. In particular, the Company has regained compliance with the continued listing requirement under NYSE American Company
Guide Section 1003(a)(iii). That section requires a listed issuer to maintain stockholders’ equity of at least $6 million
if it has reported losses from continuing operations, and/or net losses, in its five most recent fiscal years. The return to compliance
was achieved as a result of the Company’s recently-consummated public offering, in which the Company raised approximately
$10.7 million of net proceeds from the sale of units and pre-funded units.
A
copy of the above-referenced press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
|
InspireMD,
Inc.
|
|
|
|
Date:
August 10, 2020
|
By:
|
/s/
Craig Shore
|
|
Name:
|
Craig
Shore
|
|
Title:
|
Chief
Financial Officer
|
InspireMD (AMEX:NSPR)
Historical Stock Chart
From Apr 2024 to May 2024
InspireMD (AMEX:NSPR)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about InspireMD Inc New (American Stock Exchange): 0 recent articles
More Inspiremd, Inc. News Articles